NeuPath Health Inc.
NPTH.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.20% | 17.58% | 15.55% | 11.35% | 7.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.20% | 17.58% | 15.55% | 11.35% | 7.09% |
| Cost of Revenue | 20.48% | 17.58% | 15.24% | 11.27% | 6.56% |
| Gross Profit | 19.01% | 17.60% | 16.88% | 11.65% | 9.39% |
| SG&A Expenses | 18.91% | 18.68% | 13.59% | 8.73% | 5.96% |
| Depreciation & Amortization | -2.90% | -2.24% | -7.99% | -9.34% | -12.31% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.52% | 17.09% | 14.19% | 10.16% | 5.75% |
| Operating Income | 50.80% | 42.17% | 99.05% | 93.05% | 146.74% |
| Income Before Tax | 455.07% | 83.13% | 135.64% | -144.03% | -210.58% |
| Income Tax Expenses | 9.93% | 64.19% | 162.61% | 45.56% | 10.31% |
| Earnings from Continuing Operations | 164.49% | 18.99% | 64.37% | -8,146.51% | -45.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.26% | -22.71% | -59.79% | -283.90% | -1,741.09% |
| Net Income | 101.31% | 5.12% | 38.44% | -952.21% | -153.52% |
| EBIT | 50.80% | 42.17% | 99.05% | 93.05% | 146.74% |
| EBITDA | 37.40% | 33.23% | 33.39% | 26.50% | 26.92% |
| EPS Basic | 101.04% | 5.26% | 38.39% | -910.00% | -152.63% |
| Normalized Basic EPS | 638.46% | 783.33% | 781.82% | 566.67% | 152.00% |
| EPS Diluted | 100.74% | 22.14% | 43.95% | -314.71% | -119.35% |
| Normalized Diluted EPS | 607.69% | 750.00% | 763.64% | 544.44% | 152.00% |
| Average Basic Shares Outstanding | 0.09% | 0.02% | 0.15% | 0.19% | 0.36% |
| Average Diluted Shares Outstanding | 2.32% | 1.69% | 1.82% | 0.95% | 0.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |